Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer
Yoko Kataoka(Shiga University of Medical Science), Jun Hanaoka(Shiga University of Medical Science)
Cited by 27
Related Papers
Cancer‐associated fibroblast‐targeted strategy enhances antitumor immune responses in dendritic cell‐based vaccine
|Cancer Science|2014|88
Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors
|ESMO Open|2016|80
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
|Lung Cancer|2019|59
Predictive biomarkers and effectiveness of MUC1-targeted dendritic-cell-based vaccine in patients with refractory non-small cell lung cancer
|Therapeutic Advances in Medical Oncology|2016|27
Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer
|Cancer Immunology Immunotherapy|2020|12